-
1
-
-
0026895216
-
The evaluation of clinical results of hepatic artery embolization
-
Slomka M, Radwan P. The evaluation of clinical results of hepatic artery embolization. Mater Med Pol 1992;24(3):193-195.
-
(1992)
Mater Med Pol
, vol.24
, Issue.3
, pp. 193-195
-
-
Slomka, M.1
Radwan, P.2
-
2
-
-
0021960343
-
Therapeutic embolisation of the hepatic artery: A review of 75 procedures
-
Allison DJ, Jordan H, Hennessy O. Therapeutic embolisation of the hepatic artery: a review of 75 procedures. Lancet 1985;1: 595-598.
-
(1985)
Lancet
, vol.1
, pp. 595-598
-
-
Allison, D.J.1
Jordan, H.2
Hennessy, O.3
-
3
-
-
0020577795
-
Transcatheter embolization of hepatocellular carcinoma: Assessment of efficacy in cases of resection following embolization
-
Nakamura H, Tanaka T, Hori S, et al. Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization. Radiology 1983;147:401-405.
-
(1983)
Radiology
, vol.147
, pp. 401-405
-
-
Nakamura, H.1
Tanaka, T.2
Hori, S.3
-
4
-
-
0021930840
-
Preoperative angioinfarction of localized renal cell carcinoma using absolute ethanol
-
Klimberg I, Hunter P, Hawkins IF, Drylie DM, Wajsman Z. Preoperative angioinfarction of localized renal cell carcinoma using absolute ethanol. J Urol 1985;133:21-24.
-
(1985)
J Urol
, vol.133
, pp. 21-24
-
-
Klimberg, I.1
Hunter, P.2
Hawkins, I.F.3
Drylie, D.M.4
Wajsman, Z.5
-
5
-
-
0036234781
-
Reduction of postembolization syndrome after ablation of renal angiomyolipoma
-
Bissler JJ, Racadio J, Donnelly LF, Johnson ND. Reduction of postembolization syndrome after ablation of renal angiomyolipoma. Am J Kidney Dis 2002;39:966-971.
-
(2002)
Am J Kidney Dis
, vol.39
, pp. 966-971
-
-
Bissler, J.J.1
Racadio, J.2
Donnelly, L.F.3
Johnson, N.D.4
-
6
-
-
0026949340
-
Changes in IL-6, IL-8, C-reactive protein and pancreatic secretory trypsin inhibitor after transcatheter arterial chemoembolization therapy f or hepatocellular carcinoma
-
Ikei S, Ogawa M, Beppu T, et al. Changes in IL-6, IL-8, C-reactive protein and pancreatic secretory trypsin inhibitor after transcatheter arterial chemoembolization therapy f or hepatocellular carcinoma. Cytokine 1992;4:581-584.
-
(1992)
Cytokine
, vol.4
, pp. 581-584
-
-
Ikei, S.1
Ogawa, M.2
Beppu, T.3
-
7
-
-
0032997106
-
Hepatic damage induced by transcatheter arterial chemoembolization elevates serum concentrations of macrophage-colony stimulating factor
-
Itoh Y, Okanoue T, Ohnishi N, et al. Hepatic damage induced by transcatheter arterial chemoembolization elevates serum concentrations of macrophage-colony stimulating factor. Liver 1999;19:97-103.
-
(1999)
Liver
, vol.19
, pp. 97-103
-
-
Itoh, Y.1
Okanoue, T.2
Ohnishi, N.3
-
8
-
-
0028039799
-
Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma: Effects of serine protease inhibitor
-
Matsuda Y, Kawata S, Nagase T, et al. Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma: effects of serine protease inhibitor. Cancer 1994;73:53-57.
-
(1994)
Cancer
, vol.73
, pp. 53-57
-
-
Matsuda, Y.1
Kawata, S.2
Nagase, T.3
-
9
-
-
0012040631
-
Radiofrequency thermal ablation of hepatic tumors: Post ablation syndrome
-
Rhim H, Choi J, Kim Y, et al. Radiofrequency thermal ablation of hepatic tumors: post ablation syndrome [abstr]. J Vasc Interv Radiol 2000;11(suppl 2):271-272.
-
(2000)
J Vasc Interv Radiol
, vol.11
, Issue.SUPPL. 2
, pp. 271-272
-
-
Rhim, H.1
Choi, J.2
Kim, Y.3
-
10
-
-
0012313891
-
Post ablation syndrome following radiofrequency ablation thermal ablation of liver tumors
-
Kauai, Hawaii, March 12
-
Napier D, Dodd G, Hubbard L, et al. Post ablation syndrome following radiofrequency ablation thermal ablation of liver tumors. Presented at the 29th annual scientific meeting of the Society of Gastrointestinal Radiology, Kauai, Hawaii, March 12, 2000.
-
(2000)
29th Annual Scientific Meeting of the Society of Gastrointestinal Radiology
-
-
Napier, D.1
Dodd, G.2
Hubbard, L.3
-
11
-
-
4644308411
-
Adverse events during radiofrequency treatment of 582 hepatic tumors
-
de Baere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003;181:695-700.
-
(2003)
AJR Am J Roentgenol
, vol.181
, pp. 695-700
-
-
Baere, T.1
Risse, O.2
Kuoch, V.3
-
12
-
-
0036482038
-
Complications from radiofrequency ablation of liver metastases
-
Zagoria RJ, Chen MY, Shen P, et al. Complications from radiofrequency ablation of liver metastases. Am Surg 2002;68:204-209.
-
(2002)
Am Surg
, vol.68
, pp. 204-209
-
-
Zagoria, R.J.1
Chen, M.Y.2
Shen, P.3
-
13
-
-
0033835017
-
Radiofrequency ablation of 231 unresectable hepatic rumors: Indications, limitations, and complications
-
Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic rumors: indications, limitations, and complications. Ann Surg Oncol 2000; 7:593-600.
-
(2000)
Ann Surg Oncol
, vol.7
, pp. 593-600
-
-
Wood, T.F.1
Rose, D.M.2
Chung, M.3
-
14
-
-
0037295183
-
Treatment of focal liver tumors with percutaneous radiofrequency ablation: Complications encountered in a multicenter study
-
Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441-451.
-
(2003)
Radiology
, vol.226
, pp. 441-451
-
-
Livraghi, T.1
Solbiati, L.2
Meloni, M.F.3
|